85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust 95% of the Shares Voted Were In Favor of the Extension These Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC's Entry into a Merger Agreement with Prologium Prologium is a global leader in next generation lithium ceramic battery technology, moving into growth markets, including AI Data Centers, aerospace, robotics, defense and electric vehicles NEW YORK, June 22, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE: TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on 6/17/26 regarding the proposed extension of the SPAC life and election of shareholders to redeem their shares or continue to participate in TDAC. In connection with the meeting, holders of the Company's Class A common stock were given the opportunity to redeem their shares for a pro-rata portion of the Company's trust account.
